Cathy Tralau-Stewart discusses strengthening UK therapeutic translation in Drug Discovery World
We’re delighted that our Executive Director, Professor Cathy Tralau-Stewart, has continued her thought leadership work with Drug Discovery World, with a timely article on “The role of universities and industry in driving translation of therapeutics: the need for a new...
Functional Genomics Screening Laboratory wins OBN Award for Most Impactful Industry Collaboration
We are thrilled to announce that the Functional Genomics Screening Laboratory (FGSL) has been awarded an OBN Award in the Most Impactful Industry Collaboration category. This recognises the pioneering work taking place in the FGSL — a collaboration between the Milner...
Cathy Tralau-Stewart joins expert panel at 2025 Drug Discovery World Symposium
Milner Executive Director Cathy Tralau-Stewart was delighted to join Drug Discovery World (DDW) at their 2025 Symposium this month, which brought together leaders from drug discovery, academia, and biotech to explore how innovation can move more effectively from...
Milner Therapeutics Institute and Cambridge Network join forces to showcase MTI partnerships and enterprise
Earlier this week, we were delighted to team up with Cambridge Network to host an event at the West Hub in Cambridge. The event provided an overview of the Institute’s unique translational ecosystem, and Cambridge Network members gathered to learn more about the ways...